Heart Pump Device Market Outlook from 2024 to 2034
The global heart pump device market is expected to rise from US$ 4.0 billion in 2024 to US$ 25.4 billion by 2034. By 2034, the market is projected to surge at 20.4% CAGR.
Attributes
Key Insights
Estimated Global Heart Pump Device Market Size (2024E)
US$ 4.0 billion
Projected Heart Pump Device Market Value (2034F)
US$ 25.4 billion
Value-based CAGR (2024 to 2034)
20.4%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Heart Pump Device Market Overview
The rising prevalence of cardiovascular illnesses and the aging population are two key factors that are anticipated to fuel growth of the heart pump device market during the forecast period.
The growing market penetration of industry participants is predicted to slow down the market expansion for heart pump devices.
Post pandemic, patients with pre-existing cardiac diseases who contracted COVID-19 are more likely to suffer from a severe sickness, which led to a rising demand for heart pump devices.
2019 to 2023 Global Heart Pump Device Market Growth Outlook Vs. 2024 to 2034
The global heart pump device sales grew at a CAGR of 24.0% from 2019 to 2023. The growth of heart pump devices from 2019 to 2023 can be attributed to a convergence of factors:
In the 2020s, ventricular assist devices (VADs) became a key development in mechanical circulatory support.
VADs were first created as short-term support devices, but they have now matured into practical solutions for patients with end-stage heart failure who require long-term care.
The engineering and design of heart pump therapy devices have seen tremendous technological advances.
Innovations, including wireless monitoring capabilities, compacted devices, and magnetically levitated centrifugal flow pumps, have improved device performance, durability, and patient outcomes.
Clinical research and trials have advanced the field of mechanical circulatory support significantly.
Extensive clinical trials have produced data regarding heart pump devices' effectiveness, safety, and long-term consequences, influencing treatment choices and developing clinical practice standards.
By 2034, the market for heart pump devices is expected to rise at 20.4% CAGR.
Patient-centric care, which encompasses individualized treatment plans catered to each patient's needs, is gaining traction in the healthcare sector.
Companies are creating remote monitoring programs and customizable heart pump systems that let medical professionals give the best possible care for their patients and achieve better results.
Leading economies are focusing on healthcare infrastructure advancement. This offers substantial prospects for market growth for heart pump device producers, particularly as these areas deal with the rising prevalence of cardiovascular illnesses.
Find your sweet spots for generating winning opportunities in this market.
Key Heart Pump Device Market Trends
Substantial technological developments in the heart pump device market aim to enhance devices' effectiveness, longevity, and patient outcomes. These include creating smaller, more effective devices as well as improving control systems and the materials used to build them.
Heart failure is becoming a more common illness worldwide as a result of aging populations and increased rates of cardiovascular diseases.
Less invasive methods are gaining traction among patients and medical professionals to treat cardiac diseases. This tendency impacts the creation of less invasive implantable cardiac pumps, which, compared to open heart surgery, have lower risks and faster recovery times.
Restraining Factors in the Heart Pump Device Market
Even with the latest technological breakthroughs, heart pump systems are still susceptible to complications such as thrombosis, infection, and device malfunctioning.
Several healthcare facilities need more knowledge or resources to implement & maintain cardiac pump devices safely and efficiently. This restriction limits the broad use of heart pump devices, especially in underserved or rural locations.
The most effective treatment for end-stage heart failure is still heart transplantation. However, there is a shortage of appropriate donor hearts, which causes transplant candidates to have to wait a lengthy time for a transplant.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Comparative View of Adjacent Markets
A comprehensive analysis of growth and challenges has been tabulated below. The heart pump device market is compared with two industries that have the potential to compete rigorously: the portable medical device market and the cardiovascular needle market.
The growth rates and key market trends are mentioned in the table below. Among the mentioned markets, the heart pump device market is poised to rise more rapidly during the forecast period.
Heart Pump Device Market:
Attributes
Heart Pump Device Market
CAGR (2024 to 2034)
20.4%
Heart Pump Device Market Opportunities
Pharmaceutical corporations and medical equipment makers continue to invest heavily in the research & development of heart pump technologies. Pharmacies are investigating cutting-edge technologies like magnetically levitated centrifugal-flow pumps to enhance device dependability and lessen issues related to conventional pumps.
Key Trends
Rising healthcare spending, especially in emerging nations, facilitates the adoption of cutting-edge medical technologies, such as heart pump devices. Heart pump devices are predicted to be highly demanded as access to specialized treatment increases and healthcare infrastructure improves.
Portable Medical Device Market:
Attributes
Portable Medical Device Market
CAGR (2024 to 2034)
10.7%
Opportunity
Portable medical devices are integrating AI and machine learning algorithms to evaluate medical data, identify trends, and offer individualized insights & suggestions.
Key Trends
The need for portable medical gadgets that enable virtual consultations and remote diagnostics is increasing due to the growth of telehealth and telemedicine services.
Cardiovascular Needle Market:
Attributes
Cardiovascular Needle Market
CAGR (2024 to 2034)
7.5%
Opportunity
Minimally invasive cardiovascular operations such as cardiac catheterization, angioplasty, and angiography call for specific needles. Manufacturers are creating needles with smaller diameters, sharper tips, and more flexibility to improve access to difficult anatomical regions and lessen patient discomfort.
Key Trends
The need for cardiovascular operations and related medical equipment, such as needles, is being driven by the rising prevalence of cardiovascular disorders worldwide, such as heart failure, hypertension, and coronary artery disease.
Country-wise Insights
The table below shows the estimated growth rates of the top five countries. South Korea, the United Kingdom, and China are set to record high CAGRs of 22.2%, 21.5%, and 21.7%, respectively, through 2034.
Countries
Projected CAGR (2034)
United States
20.7%
United Kingdom
21.5%
China
21.7%
South Korea
22.2%
Japan
18.6%
The table below explains the heart pump device market size of the top five countries for 2034. Among them, the United States is anticipated to remain at the forefront by reaching a valuation of US$ 4.5 billion. Japan is expected to reach around US$ 2.3 billion by 2034, less than China's US$ 4.3 billion.
Countries
Market Values
United States
US$ 4.5 billion
United Kingdom
US$ 1 billion
China
US$ 4.3 billion
South Korea
US$ 1.5 billion
Japan
US$ 2.3 billion
Rising Prevalence of Obesity and Hypertension to Boost the United States
The United States heart pump device industry is poised to exhibit a CAGR of 20.7% during the assessment period. By 2034, the United States market is expected to reach US$ 4.5 billion. The key factors supporting the market growth are:
With a sizable percentage of the population suffering from heart failure and illness, it is still a major public health concern in the United States.
Heart pump devices are gaining traction in the United States as a therapeutic alternative as the population ages, and risk factors like obesity and hypertension become more common.
The most popular heart pump device in the United States is the Left Ventricular Assist Device (LVAD).
The growing use of LVADs results from wider indications for usage, better patient outcomes, and developments in device technology.
Growing Clinical Research and Trials Propelling Demand in China
Heart pump device demand in China is anticipated to rise at a steady CAGR of 21.7% during the forecast period. This is attributable to a combination of factors, including:
The acceptance and use of heart pump devices in China are heavily influenced by reimbursement guidelines and coverage choices made by commercial insurers & government payers.
Clinical research and trials in China are essential to advancing heart pump technology.
The report generated by clinical studies regarding device safety, effectiveness, and long-term results influences clinical practice guidelines and treatment decisions.
China's regulatory environment is changing to guarantee the effectiveness and safety of medical devices, particularly heart pump devices.
Technological Innovations in Japan Paving the Road for Success
Japan's heart pump device market is expected to reach a valuation of around US$ 2.3 billion by 2034. Top factors supporting the market expansion in the country include:
Japan is spending more on healthcare to advance cutting-edge medical technologies, increase access to healthcare services, and enhance healthcare infrastructure.
Technological development in the device’s design is set to stimulate market expansion and adoption by enhancing device performance, dependability, and patient outcomes.
Growing Consumer Knowledge and Acceptance Upscaling the United Kingdom
The demand for heart pump devices is increasing in the United Kingdom, with a projected CAGR of 21.5% through 2034. Emerging patterns in the United Kingdom market are as follows:
The advantages of heart pump devices in treating advanced heart failure are becoming widely known among patients and healthcare professionals in the United Kingdom.
Heart pump devices are increasingly accepted and used as therapeutic options in the United Kingdom, particularly when traditional treatments do not work.
Rising Local and Foreign Firms in South Korea Boost Heart Pump Device Adoption
The heart pump device market is projected to increase in South Korea at a CAGR of 22.2% through 2034. The factors driving the market growth are as follows:
Local and foreign firms are vying for market share in South Korea's heart pump technology industry.
Domestic companies are investing more in research and development to compete with well-established multinational firms and create cutting-edge products in South Korea.
Technological advancements, including downsized devices, magnetically levitated centrifugal-flow pumps, and remote monitoring capabilities, are propelling the market's expansion and enhancing the standard of care for patients.
Category-wise Insights
The section below shows the implanted heart pump devices segment dominating by type. The segment is predicted to surge at a 20.0% CAGR through 2034. Based on the product, the ventricular assist devices (VADs) segment is anticipated to generate a dominant share through 2024. It is expected to rise at a CAGR of 19.6% through 2034.
Segment
CAGR (2034)
Implanted Heart Pump Devices [Type]
20.0%
Ventricular Assist Devices (VADs) [Product]
19.6%
Implanted Heart Pump Devices to Dominate the Market through 2034
Based on type, the demand for implanted heart pump devices is expected to remain high during the evaluation period.
Implanted heart pump devices are gaining traction among heart failure patients who are not eligible for heart transplantation.
Technological developments and product innovations in heart pump implantation are expected to fuel this segment's continued expansion.
With smaller, more effective devices that require less invasive procedures being developed by manufacturers, implanted heart pump devices use as a therapy option for heart failure patients is predicted to rise.
Ventricular Assist Devices (VADs) Top the Product Category
Based on the product, ventricular assist devices (VADs) are expected to surge at a CAGR of 19.6% through 2034.
Due to the growing prevalence of heart failure and developments in device technology, the demand for VADs is rising.
As the population ages and the prevalence of heart failure increases, the market for VADs is anticipated to expand further.
Continuous technical development aimed at enhancing device performance, longevity, and patient outcomes characterizes the VAD market.
Miniaturized devices, wireless monitoring capabilities, and magnetically levitated centrifugal flow pumps are examples of innovations that are improving device reliability and decreasing difficulties.
Competitive Landscape
Collaborations between medical device companies, research institutions, and healthcare providers are becoming increasingly common. These partnerships facilitate the exchange of knowledge and resources, accelerating the development and adoption of innovative heart pump devices.
Key firms are pursuing strategic initiatives to optimize their market domination, such as acquisitions, mergers, and collaborations. They are introducing cutting-edge products at competitive rates.
For instance
In December 2022, Johnson & Johnson acquired Abiomed, Inc. It is expected to operate independently within Johnson & Johnson's MedTech segment.
In 2022, Abiomed declared that the FDA approved two clinical research projects involving Impella heart pumps in individuals suffering from acute myocardial infarction (AMI) and cardiogenic shock.
In 2022, the School of Medical Research and Technology (SMRT) at IIT Kanpur announced the opening of Hridyantra, a challenge-based initiative to create a cutting-edge artificial heart.
Key Companies Profiled
Abbott
ABIOMED
CorWave SA
LivaNova PLC
Berlin Heart
SynCardia Systems
LLC
Jarvik Heart
BiVACOR Inc.
Heart Pump Device Market Segmentation by Category
By Type:
Implanted Heart Pump Devices
Extracorporeal Heart Pump Devices
By Product:
Ventricular Assist Devices (VADs)
Left Ventricular Assist Devices (LVAD)
Right Ventricular Assist Devices (RVAD)
Bi-ventricular Assist Devices (BiVAD)
Percutaneous Ventricular Assist Devices (PVAD)
Total Artificial Hearts (TAHs)
Intra-aortic Balloon Pumps (IABPs)
Extracorporeal Membrane Oxygenation (ECMO)
By End-use:
Hospitals
Cardiac Centers
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Frequently Asked Questions
How big is the heart pump device market?
The market is set to reach US$ 4.0 billion in 2024.
What is the forecast for the heart pump device market?
Demand for heart pump devices is slated to expand at a 20.4% CAGR by 2034.
What is the outlook for the heart pump device market?
The market is expected to reach US$ 25.4 billion in 2034.
Who are the key players in the heart pump device market?
Abbott, ABIOMED, and CorWave SA are the key players.
Which type would lead the heart pump device market?
The implanted heart pump devices segment is estimated to hold a significant market share.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ billion) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ billion) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ billion) & Volume (Units) Analysis By Type, 2019 to 2023
5.3. Current and Future Market Size Value (US$ billion) & Volume (Units) Analysis and Forecast By Type, 2024 to 2034
5.3.1. Implanted Heart Pump Devices
5.3.2. Extracorporeal Heart Pump Devices
5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ billion) & Volume (Units) Analysis By Product, 2019 to 2023
6.3. Current and Future Market Size Value (US$ billion) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034
6.3.1. Ventricular Assist Devices (VADs)
6.3.1.1. Left Ventricular Assist Devices (LVAD)
6.3.1.2. Right Ventricular Assist Devices (RVAD)
6.3.1.3. Bi-ventricular Assist Devices (BiVAD)
6.3.1.4. Percutaneous Ventricular Assist Devices (PVAD)
6.3.2. Total Artificial Hearts (TAHs)
6.3.3. Intra-aortic Balloon Pumps (IABPs)
6.3.4. Extracorporeal Membrane Oxygenation (ECMO)
6.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ billion) & Volume (Units) Analysis By End-use, 2019 to 2023
7.3. Current and Future Market Size Value (US$ billion) & Volume (Units) Analysis and Forecast By End-use, 2024 to 2034
7.3.1. Hospitals
7.3.2. Cardiac Centers
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By End-use, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By End-use, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ billion) & Volume (Units) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ billion) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ billion) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ billion) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. United States
9.2.1.2. Canada
9.2.2. By Type
9.2.3. By Product
9.2.4. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Product
9.3.4. By End-use
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ billion) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ billion) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Type
10.2.3. By Product
10.2.4. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Product
10.3.4. By End-use
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ billion) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ billion) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Type
11.2.3. By Product
11.2.4. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Product
11.3.4. By End-use
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ billion) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ billion) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Type
12.2.3. By Product
12.2.4. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Product
12.3.4. By End-use
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ billion) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ billion) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Type
13.2.3. By Product
13.2.4. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Product
13.3.4. By End-use
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ billion) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ billion) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Type
14.2.3. By Product
14.2.4. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Product
14.3.4. By End-use
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ billion) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ billion) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of Middle East and Africa
15.2.2. By Type
15.2.3. By Product
15.2.4. By End-use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type
15.3.3. By Product
15.3.4. By End-use
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. United States
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Type
16.1.2.2. By Product
16.1.2.3. By End-use
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Type
16.2.2.2. By Product
16.2.2.3. By End-use
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Type
16.3.2.2. By Product
16.3.2.3. By End-use
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Type
16.4.2.2. By Product
16.4.2.3. By End-use
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Type
16.5.2.2. By Product
16.5.2.3. By End-use
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Type
16.6.2.2. By Product
16.6.2.3. By End-use
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Type
16.7.2.2. By Product
16.7.2.3. By End-use
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Type
16.8.2.2. By Product
16.8.2.3. By End-use
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Type
16.9.2.2. By Product
16.9.2.3. By End-use
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Type
16.10.2.2. By Product
16.10.2.3. By End-use
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Type
16.11.2.2. By Product
16.11.2.3. By End-use
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Type
16.12.2.2. By Product
16.12.2.3. By End-use
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Type
16.13.2.2. By Product
16.13.2.3. By End-use
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Type
16.14.2.2. By Product
16.14.2.3. By End-use
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Type
16.15.2.2. By Product
16.15.2.3. By End-use
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Type
16.16.2.2. By Product
16.16.2.3. By End-use
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Type
16.17.2.2. By Product
16.17.2.3. By End-use
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Type
16.18.2.2. By Product
16.18.2.3. By End-use
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Type
16.19.2.2. By Product
16.19.2.3. By End-use
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Type
16.20.2.2. By Product
16.20.2.3. By End-use
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Type
16.21.2.2. By Product
16.21.2.3. By End-use
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Type
16.22.2.2. By Product
16.22.2.3. By End-use
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2023
16.23.2.1. By Type
16.23.2.2. By Product
16.23.2.3. By End-use
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Type
17.3.3. By Product
17.3.4. By End-use
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Abbott
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. ABIOMED
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. CorWave SA
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. LivaNova PLC
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Berlin Heart
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. SynCardia Systems, LLC
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Jarvik Heart
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. BiVACOR Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Leviticus Cardio
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Evaheart, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Teleflex Incorporated.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Getinge AB.
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. CARMAT
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
19. Assumptions & Acronyms Used20. Research Methodology
